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Abstract
Cellular functions are largely regulated by reversible post-translational modifications of pro-
teins which act as switches. Amongst these, S-palmitoylation is unique in that it confers
hydrophobicity. Due to technical difficulties, the understanding of this modification has
lagged behind. To investigate principles underlying dynamics and regulation of palmitoyla-
tion, we have here studied a key cellular protein, the ER chaperone calnexin, which requires
dual palmitoylation for function. Apprehending the complex inter-conversion between sin-
gle-, double- and non- palmitoylated species required combining experimental determina-
tion of kinetic parameters with extensive mathematical modelling. We found that calnexin,
due to the presence of two cooperative sites, becomes stably acylated, which not only con-
fers function but also a remarkable increase in stability. Unexpectedly, stochastic simula-
tions revealed that palmitoylation does not occur soon after synthesis, but many hours later.
This prediction guided us to find that phosphorylation actively delays calnexin palmitoylation
in resting cells. Altogether this study reveals that cells synthesize 5 times more calnexin
than needed under resting condition, most of which is degraded. This unused pool can be
mobilized by preventing phosphorylation or increasing the activity of the palmitoyltransfer-
ase DHHC6.
Author Summary
The endoplasmic reticulum (ER) is the largest intracellular organelle of mammalian cells.
It is responsible for many fundamental cellular functions, such as folding, quality control
of membrane and secreted protein, lipid biosynthesis, control of apoptosis and calcium
storage. Recent studies have shown that many ER membrane proteins are lipid modified.
We therefore hypothesized that palmitoyltransferases, the enzymes responsible for this
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modifications, act as a regulator of the mammalian ER, controlling the function of a net-
work of key proteins through reversible acylation. In this work we combine computational
methods with experimental determination of parameters to study the mechanisms and
properties of ER palmitoylation, using as a model the palmitoylation of the ER protein cal-
nexin. The systematic analysis of the mathematical model, built and calibrated with the
help of experimental data, shows that Calnexin palmitoylation leads to a 9-fold increase in
half-life and that a long delay separates synthesis from palmitoylation in unstimulated
cells. Surprisingly during this delay, 75% of synthesized calnexin is degraded before being
palmitoylated. We hypothesize that this unexpected apparent inefficiency is a design prin-
ciple that provides the cell with a means to post-translationally tune the calnexin content.
Introduction
Reversible post-translational modifications of proteins allow cells to regulate processes in time
and in space [1–5]. Amongst these, S-palmitoylation is unique in that in confers hydrophobic-
ity to proteins by covalent attachment of a fatty acid chain to cysteine residues [6, 7] [8]. In the
cytoplasm, this enzymatic reaction is mediated by palmitoyltransferases of the DHHC family
and reversed by acyl protein thioesterases (APTs) [6, 7, 9]. Recent large-scale palmitoyl-prote-
ome profiling studies have jointly revealed that hundreds of proteins, with major cellular func-
tions, undergo this lipid modification in mammalian cells [10–14]. Although S-palmitoylation
was identified more than 30 years ago, our understanding of this modification, its dynamics, its
regulation and its consequences on protein properties, is still rudimentary.
The aim of this paper is to study the palmitoylation events, and their dynamics, occurring
on a key component of the endoplasmic reticulum (ER), the type I transmembrane protein cal-
nexin. Here we report the step-by-step design and output analysis of the first model of a palmi-
toylation network. Besides studying palmitoylation, another valuable objective of this work has
been the estimation of system parameters which cannot be estimated by simple experiments,
such as the time required for calnexin to get double palmitoylated or the half life of the palmi-
toylated species, but instead, they require the consideration of the system as a whole.
Calnexin is best known for its function as a lectin-like chaperone involved in the folding of
glycosylated proteins in the lumen of the ER [15]. It is also involved in regulating calcium
homeostasis at ER-mitochondria contact sites [16]. More recently, we have found that calnexin
can act as an ER sensor, modulating the transcriptional response of cells to EGF in an ER-stress
dependent manner [17]. Importantly, the ability of calnexin to assist folding of newly synthe-
sized proteins, to control calcium signalling and to modulate the EGF signalling response, all
require its palmitoylation [16–19].
Calnexin is composed of a large well-folded N-terminal luminal domain that carries the
chaperone activity [20]. It is followed by a single transmembrane domain that terminates with
two cysteine residues at positions 502 and 503, which are the sites of palmitoylation [18, 19].
Even though the ER contains numerous DHHC enzymes [21], calnexin palmitoylation is medi-
ated exclusively by DHHC6 [19]. The palmitoylation sites are followed by a 90 residue cytosolic
tail that is predicted to be disordered and contains multiple phosphorylation sites [20]. This
cytosolic domain has multiple functions. It allows association of calnexin with the ribosome
translocon complex [19, 22] but can also be proteolytically released following specific stimuli
such as apoptotic drugs [23] or EGF [17]. In the latter case, the released cytosolic tail binds to
PIAS3 (Protein Inhibitor of Activated STAT) and thereby promotes EGF-induced STAT3-me-
diated transcriptional response to EGF [17].
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Since calnexin has two sites of palmitoylation, it can exist in cells under different forms:
non-modified, palmitoylated on one site or the other, or on both. To grasp the full complexity
of the system, we combined mathematical modelling of the system with experimental determi-
nation of the kinetics of palmitate acquisition and turnover, and of protein degradation for
wild type (WT) and palmitoylation-deficient mutants. We set up a general model consisting of
ordinary differential equations (ODE), describing the dynamic transitions between states/spe-
cies of the network. We defined the topology of our network as a combination of well-known
inter-convertible cycles described by Goldbeter and Koshland [24]. Combinations of such sub-
units have been used to successfully describe biological systems in which proteins undergo
multiple covalent modifications, especially in the context of protein kinase signalling networks
[25–27]. Since palmitoylation has, as phosphorylation, the potential to control protein function
in a switch-like manner, a similar approach appeared suitable to model calnexin
palmitoylation.
Mathematical modelling allowed us to access an unprecedented level of understanding of
the dynamics and the complexity of inter-convertible species of the same protein undergoing
various post-translational modifications on multiple sites and access key parameters that are
not directly measurable through experimentation. We could in particular estimate the half-life
of single or dual palmitoylated calnexin, the off-rate of palmitate from a specific site upon
occupancy of the other site or the time that separates calnexin synthesis from palmitoylation
events, all together revealing the existence of a regulatory system that allows cells to post-trans-
lationally control the cellular levels and thus activity of this key ER chaperone.
Results
Mathematical model of calnexin palmitoylation
Calnexin was recently shown to rely on palmitoylation to perform its major functions [17–19,
28]. This raises the question as to which percentage of the total calnexin population is at a
given time palmitoylated. At present, no reliable method enables to determine the percentage
of a protein that is palmitoylated and to differentiate single from double palmitoylation. To
estimate the species distribution and understand the dynamics of the inter-conversion between
them, we therefore developed a mathematical model of the calnexin palmitoylation cycle.
Modelling was performed as an open system, including protein synthesis, and degradation of
all species (S1 Table, Fig 1A).
Calnexin is synthesized by ER-associated ribosomes and inserted into the ER membrane
(represented by rCAL). Presumably already co-translationally, the calnexin luminal domain
undergoes folding, a process that is very efficient as discussed below. The cytosolic tail of cal-
nexin is predicted to be highly disordered (IUPRED [29], http://iupred.enzim.hu/). fCAL rep-
resents folded but non-palmitoylated calnexin. This species can be modified on the first or
second palmitoylation site leading to c1CAL and c2CAL, respectively. Single palmitoylated
species can acquire a second palmitate both leading to c12CAL (Fig 1A). The palmitoyltrans-
ferase DHHC6 catalyses the palmitoylation reaction for each site [19]. Depalmitoylation,
which requires acyl protein thioesterases [8], the identity of which remain to be established for
calnexin, can occur from both sites.
The individual palmitoylation and depalmitoylation steps were assumed to follow irrevers-
ible Michaelis-Menten kinetics, similar to the kinetics used in signalling network models [30].
These kinetics were determined using the total quasi steady state approximation (tQSSA) to a
mass action model [31–33] reported by Pedersen et al. for the study of phosphorylation and
dephosphorylation cycles [34, 35]. This approach included a step-by-step application of tQSSA
to a variety of biochemical reactions and contained a formulation of tQSSA for systems with
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Fig 1. Calnexin palmitoylation model and kinetics of decay. A: Calnexin is first synthesized (rCAL). During the folding process the protein assumes the
proper conformation (fCAL), which then can be palmitoylated twice by DHHC6. The first palmitoylation can occur on either of the two sites leading to c1CAL
or c2CAL. The second palmitoylation events leads to c12CAL. We assume that both palmitoylation steps are reversible. Degradation can occur from all
states.B-E: HeLa cells were transfected or not for 24h with calnexin-WT-HA, HA-calnexin-KDEL, calnexin-CA-HA, calnexin-AC-HA, calnexin-AA-HA and
with or without DHHC6-myc, or additional transfected for 72h with DHHC6 siRNA. Cells were incubated 20 min pulse at 37°C with 35S-methionine/cysteine,
washed and further incubated for different times at 37°C. Calnexin was immunoprecipitated and analyzed by SDS-PAGE. Autoradiography (B) and western
blotting were quantified using the Typhoon Imager (Image QuantTool, GE healthcare). C: Decay profile of WT calnexin (Calx-WT) and of a calnexin mutant in
which the transmembrane and cytosolic domain were removed and replaced by the KDEL sequence for ER retention (Calx-KDEL). Errors correspond to
standard deviations (n = 7 for Calx-WT, n = 3 for Calx-KDEL). D: Decay profile of WT calnexin was observed under normal condition (Ctrl) and after
overexpression (DHHC6 Overexpression) or silencing (DHHC6 Silencing) of DHHC6. Errors correspond to standard deviations (n = 7, 3, 3 for Crtl, DHHC6
overexpression and silencing respectively). E: Decay profile of WT calnexin (Calx-WT) and different mutants, in which site c1 (Calx-AC), site c2 (Calx-CA), or
both palmitoylation sites (Calx-AA) were mutated. Errors correspond to standard deviations (n = 8, 3, 3, 3 for Calx-WT, AC, CA and AA respectively).
doi:10.1371/journal.pcbi.1004774.g001
Palmitoylation Dynamics of the Chaperone Calnexin
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004774 February 22, 2016 4 / 23
competitive inhibition. As Gunawardena and colleagues pointed out [36] this avoids any ad
hoc assumption inherent in the common Michaelis-Menten equations and takes into account
sequestration effects when enzymes have multiple substrates. In these systems, a single enzyme
can catalyse the same reaction on multiple substrates, which is conceptually similar to multiple
sites on the same substrate. The equations could therefore be adapted to palmitoylation and
depalmitoylation of the two cytoplasmic calnexin cysteines.
Although this approximation is valid for a very wide range of enzyme-substrate concentra-
tions [34], in the case of calnexin palmitoylation, the validity of the Michaelis-Menten equations
was ensured by the relative concentration of DHHC6 with respect to calnexin. Based on quanti-
tative proteomic studies, the ratio of DHHC6-to-calnexin is indeed in the order of 1:500 [37–
39]. Since the two sites might not be equivalent and since rates might depend on the occupancy
of the neighbouring site, we introduced different Km values for each palmitoylation and depal-
mitoylation step. Also since the same enzyme catalyses the palmitoylation of both sites, a com-
petition term between the two sites was implemented in the enzymatic kinetics as described in
[35]. A similar competition term was introduced for depalmitoylation. The model also includes
degradation rates for each species, with different first-order rate constants. The description of
the rate expressions, the definition of the parameters, and the assumptions used in the develop-
ment of the model are described in detail in the Expanded View (S1 Fig and S1–S3 Tables).
Experimental analysis of the effect of palmitoylation on calnexin stability
Sets of experimental data were generated to calibrate and test the predictability of the model.
Since degradation of all species was included in the model, we first monitored protein degrada-
tion kinetics using 35S Cys/Met metabolic pulse-chase experiments. This requires immuno-pre-
cipitation of calnexin which we performed either using a polyclonal antibody against the C-
terminus to follow the endogenous protein, or using an anti-HA antibody to follow transiently
transfected WT and calnexin-HA mutants. WT calnexin, endogenous or HA-tagged, showed
identical biphasic decays, with a t1/2 of ca. 8h (shown only for calnexin-HA Fig 1B–1E).
The faster initial decay made us wonder what the contribution is of the luminal domain, the
largest domain of calnexin, in shaping this decay curve. We generated a truncated version of
calnexin consisting of the luminal domain fused to the KDEL sequence to ensure ER localiza-
tion. HA-calnexin-KDEL was far more stable than the full-length protein (Fig 1B and 1C). In
particular there was no decay at early time points indicating that the luminal domain under-
goes efficient folding. Thus the initial decay phase observed for the full-length protein must be
dictated by transmembrane domain and/or the cytosolic tail of calnexin.
Decay of full-length calnexin was accelerated by silencing the DHHC6 enzyme (Fig 1D), or
by mutating one or both of the palmitoylation sites (Fig 1E). In reverse, calnexin decay was slo-
wed down by overexpression of DHHC6 (Fig 1D). Based on these metabolic 20 min pulse-
chase experiments, the apparent half-life of WT calnexin is ca. 8h, while that of non-palmitoy-
lated calnexin, obtained either through enzyme silencing or site mutation, is ca. 5h.
Experimental determination of palmitate turnover on Calnexin
To further fuel the mathematical model of the palmitoylation cycle with experimental data, we
determined the turnover of the palmitate moiety once attached to calnexin. To do so, we per-
formed pulse-chase experiments using 3H-palmitate, followed by immunoprecipitation of cal-
nexin. Following a 2 h 3H-palmitate pulse, loss of 3H-palmitate fromWT calnexin occurred
with an apparent half-life of ca. 8 hrs and was somewhat accelerated in single cysteine mutants
(Fig 2A and 2B). We also monitored the kinetics of incorporation of 3H-palmitate into calnexin
(Fig 2C and 2D). This was performed in the presence of cycloheximide, to prevent synthesis of
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Fig 2. Experiments andmodelling of Palmitoylation/depalmitoylation of calnexin. AB: HeLa cells were transfected for 24h with calnexin-WT-HA,
calnexin-CA-HA, or calnexin-AC-HA. Cells were incubated with 3H-palmitic acid for 2h, washed and further incubated for different times at 37°C in complete
medium prior to immunoprecipitation using anti-calnexin or anti-HA antibodies. Immunoprecipitates were split into two, run on SDS-PAGE and analyzed
either by autoradiography (3H-palmitate) or Western blotting (anti-HA). Autoradiograms were quantified using the Typhoon Imager (Image QuantTool, GE
healthcare). Errors correspond to standard deviations (n = 3). CD: HeLa cells were incubated with 3H-palmitic acid for different times at 37°C, washed prior to
immunoprecipitation using anti-calnexin antibodies. Immunoprecipitates were split into two, run on SDS-PAGE and analyzed either by autoradiography (3H-
palmitate) or Western blotting (anti-calnexin). Errors correspond to standard deviations (n = 4). E: Validation of the model output though comparison of the in
silico experiments with experimental data that was not used in the calibration of the model. Solid line is the mean of the simulations of 382 models; the
shaded area is defined by the first and the third quartile of the simulations of 382 models (details of the in silico labelling experiment can be found in the
Supplemental Information).
doi:10.1371/journal.pcbi.1004774.g002
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new proteins during the labelling time. Degradation was not prevented with any drug. Palmi-
tate incorporation increased as a function of time and did not reach a plateau within the 7 h
time frame of the experiment. Experiments were kept within this time frame to avoid toxic/
indirect effects of prolonged inhibition of protein synthesis.
Altogether these experiments show that WT calnexin can undergo palmitoylation hours
after it has been synthesized and that turnover of palmitate is very slow.
Calibration and validation of the mathematical model
A subset of the above 35S Cys/meth and 3H-palmitate pulse-chase experiments were used to
calibrate the system, i.e. for parameter estimation, namely: decays of WT, the AC and the dou-
ble AA mutants, incorporation of 3H-palmitate into WT calnexin, 3H-palmitate turnover for
WT and the CA mutant. Since there is not a unique set of parameters that fits such a dataset,
we employed a stochastic optimization method, which allowed us to generate a population of
models, each having different combinations of parameter values while all being consistent with
the calibration experiments. From a population of 10’000 models, we selected 382 models that
best fitted the experimental data used as objective function (see Expanded View, results of the
fitting on the calibration dataset are shown in S2A–S2F Fig). The pool of selected models was
subsequently used for the simulations and analyses. Note that all generated predictions were
obtained by simulating each model independently. The outputs of all the models were then
averaged and the standard deviation with respect to the mean was used as a measure of the var-
iability among the different models (S2A–S2L Fig).
The remaining set of experiments were used to validate the output of the model, i.e. test its
predictability (see Expanded View), namely the WT calnexin decay upon DHHC6 silencing or
overexpression, the decay of the single CA cysteine mutant as well as palmitate turnover for
this mutant. As illustrated in Figs 2E and S2G–S2L, the predictions were in close agreement
with the experimental data, indicating that the model reliably describes the events of the cal-
nexin palmitoylation/depalmitoylation cycle.
Predicted species distribution of calnexin
The model was first used to determine the distribution, and the evolution thereof, of the 5 pal-
mitoylation species during the 35S-Cys/Meth pulse-chase experiments. We set up an in-silico
20 minutes labelling experiment (see Expanded View, S3 Fig) and calculated the relative con-
centrations of calnexin in the different palmitoylation states at different time points of the
chase (Fig 3A). At the end of the metabolic pulse (t = 0), the population is predicted to be
exclusively of non-palmitoylated, ca. 25% of which are already folded. Ten hours after the
pulse, the entire calnexin population was predicted to be folded, as can be expected, but, more
unexpectedly, ca. 50% was still non-palmitoylated (Fig 3A). Almost the palmitoylated species,
the dually-palmitoylated was predicted to be the most populated, with barely and single palmi-
toylated species. As chase time proceeded, the non-palmitoylated species decreased again to
the benefit of the dual palmitoylated form, which approached 90% at the end of the chase
period (Fig 3A). Note that distributions are expressed as percentages of the remaining popula-
tion, not of the initial population, which decreased by 80% between the beginning and the end
of the chase period.
This analysis indicates that the initial faster phase of degradation occurs when most of cal-
nexin is non-palmitoylated. Once a significant percentage of the population becomes acylated,
the rate of decay drastically decreases, confirming a stabilizing effect of palmitoylation.
We next determined the distribution of WT calnexin at steady state, since it may differ from
the distribution at the end of our chase period. At steady state in our Hela cells and under our
Palmitoylation Dynamics of the Chaperone Calnexin
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004774 February 22, 2016 7 / 23
Fig 3. In silico analysis of the calnexin species distribution. A:We replicated in silico the 35S pulse-chase experiment onWT calnexin. During the
experiment we monitored the relative distribution of calnexin in the different palmitoylation states. Solid line is the mean of the simulations of 382 models;
error bars are defined by the first and the third quartile of the simulations of 382 models (details of the in silico labelling experiment can be found in the
Expanded View). B: The model was used to predict the steady state distribution of WT calnexin and of the mutants in the cell. rCAL correspond to calnexin
during the synthesis, fCAL represent folded calnexin while c1CAL and c2CAL denote the two single palmitoylated species. c12CAL represents the double
palmitoylated calnexin. Error bars correspond to first and third quartile of the simulations of 382 models (details of the in silico labelling experiment can be
found in the Supplementary Information).
doi:10.1371/journal.pcbi.1004774.g003
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experimental conditions, the model predicts that ca. 70% of calnexin is dual-palmitoylated and
the remaining population is free of palmitate. The prediction that the great majority of cellular
calnexin is palmitoylated is consistent with our previous experimental evidence [19]. We noted
that palmitoylated calnexin poorly migrates in 2D gels. We subsequently compared the cal-
nexin signal by western blotting on 2D gels of control cells vs. cells silence for the DHHC6 pal-
mitoyltransferase, and found that the signal was increased by9 fold. This value is rather
qualitative given the non-linearity of western blotting, but clearly indicated that the majority of
calnexin is palmitoylated at steady state.
We next utilised the model to estimate the steady state distribution of calnexin species in
cells over-expressing DHHC6 and found that the dually-modified population increased to
almost 100% while it fell to zero upon silencing of the enzyme (Fig 3B), as expected. By regulat-
ing DHHC6 amounts and/or activity, cells thus have the potential to control the percentage of
calnexin that is dually-palmitoylated, and thus functional.
Consistent with the low population of single palmitoylated species for WT calnexin, determi-
nation of the steady state species distribution of the CA and the AC calnexin mutants revealed
that>80% of the molecules are non-palmitoylated. This indicates that to obtain a significant
population of palmitoylated calnexin, two sites are necessary. That the single palmitoylated spe-
cies do not get significantly populated was initially unexpected given the relatively small differ-
ence in the apparent palmitate turnover rates of WT and single cysteine mutants (Fig 2B). To
understand this apparent inconsistency, we used the model to predict the distribution of the spe-
cies labelled during the 2 hrs 3H-palmitate pulse (corresponding to t = 0 in Fig 2B) (S4 and S5
Figs, Supporting information). In silico, 3H-palmitate labelling shows that in 2 hrs, only a minute
percentage of the total WT population–less than 3%–undergoes labelling (S5 Fig). This is consis-
tent with the fact that 70% of the steady state population is dual palmitoylated at steady state
and can thus not be further modified upon addition of 3H-palmitate. Moreover, Fig 2D indicates
that palmitoylation can be very slow, since some proteins undergo palmitoylation 7 h or more
after having been synthesized (Fig 2D). Thus Fig 2B represents the loss of 3H-palmitate from a
population of 3H-palmitate labelled species composed roughly of 50% c1CAL and 50% c12CAL
(Fig 4A, top panel), jointly representing just 3% of the total population.
To estimate the rate of palmitate release from dually-palmitoylated calnexin (c12CAL),
which is not readily accessible experimentally, we determined what the 3H-palmitate decay
would be if the starting point was that of steady state palmitoylation, i.e. 70% calnexin dually
labelled (Fig 4A, bottom panel). Under these conditions, the loss of palmitate was significantly
slower (Fig 4B). In fact, we measured an average turnover rate for palmitate of ~32h, which is
almost 3 times slower than the apparent turnover rate estimated by our 2 hrs labelling experi-
ment. This analysis indicates that the rate constant of palmitate removal from a given site
depends on the occupancy of the second site. Our predictions indeed indicate that, in situations
of single site occupancy, the rate constants of loss of palmitate from site 1 are drastically higher
than the rate constants of loss from either site in the situation of double occupancy (Fig 4C).
Thus, single palmitoylated species do not get significantly populated as compared to the double
palmitoylated one, because they lose their palmitate at a far higher rate.
Altogether this analysis indicates that two sites are required to stably palmitoylated calnexin,
because double occupancy drastically slows down depalmitoylation.
Estimated half-lives of palmitoylated calnexin species
35S Cys/Met pulse-chase experiments of WT and cysteine mutants indicate that palmitoylation
has a stabilizing effect and that the half-life of palmitoylation deficient calnexin is ca. 5 hrs.
They however do not allow direct identification of the half-life of single or dually palmitoylated
Palmitoylation Dynamics of the Chaperone Calnexin
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calnexin. We therefore made use of the model to predict the decay kinetics of each of the cal-
nexin species (Table 1 and Fig 5A). Palmitoylation of site 1 has a mildly stabilizing effect, the
half-life of c1CAL being ca. 6.5 hrs (Fig 5A). Palmitoylation of site 2, whether site 1 is or not
modified, leads to a spectacular stabilization, with dual-palmitoylated calnexin having a pre-
dicted half-life of 45 hrs (Table 1 and Fig 5A).
We sought for an experimental confirmation for this almost 10-fold increase in protein sta-
bility. At steady state, 70% of calnexin is predicted to dually-modified (Fig 3B). To assess the
Fig 4. Prediction of depalmitoylation kinetics. A:WT calnexin was labelled with 3H-palmitate in silico either for two hrs or to reach the steady state
distribution of palmitoylation species.B: The kinetics of palmitate loss starting from the two distributions in A were determined. The solid lines represent the
means of the simulations of 382 models and the shaded areas are defined by the first and the third quartile of the simulations of 382 models (details of the in
silico labelling experiment can be found in the Expanded View). C: The rate constants for depalmitoylation from c1CAL, c2CAL and c1c2CAL where
determined. Error bars correspond to first and third quartile of the simulations of 382 models.
doi:10.1371/journal.pcbi.1004774.g004
Table 1. Half-life of the different calnexin species. The standard deviation is estimated from the 382 mod-
els (see Supplementary material).
Species Half-Life
fCAL 5.0 ± 1.5
c1CAL 6.5 ± 1.8
c2CAL 14.5 ± 1.8
c12CAL 46.0 ± 11.2
doi:10.1371/journal.pcbi.1004774.t001
Palmitoylation Dynamics of the Chaperone Calnexin
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004774 February 22, 2016 10 / 23
half-life of this population, we chose to monitor the stability of calnexin tagged with SNAP, a
widely used protein that self-labels when incubated with O6-benzylguanine derivatives [40].
We labeled cells for 30 min with SNAP-cell-TMR-star, a red fluorescent substrate of SNAP, in
order to label the entire, steady state, population of calnexin-SNAP. Following different periods
of chase, cells were harvested and the level of fluorescent calnexin was monitored by
SDS-PAGE and fluorescence scanning. As shown in Fig 5B, the decay of calnexin-
SNAP-TMR-star was slower than that observed by 35S pulse-chase, yet still biphasic. At t = 0 of
SNAP-cell-TMR-star labeling, the population of calnexin-SNAP molecules have differen-
t”ages”, the “youngest” having just been synthesized. We therefore tested whether pretreatment
of cells with cycloheximide for different times, to block protein synthesis, would affect the
apparent stability of the SNAP-cell-TMR-star labeled population. A 2 hrs cycloheximide pre-
treatment already led to an increase in apparent half-life of the population (Fig 5B). We
extended the pretreatment to 6 h, so that all calnexin molecules would be at least 6 h “old”.
With this treatment, no decay was observed for the first 24 hrs, and this was followed by a slow
decline, leading to an apparent half-life of ca. 47 hrs (Fig 5B).
Altogether, the mathematical modeling and the calnexin-SNAP tagged decay analysis indi-
cate that palmitoylation of the two juxtamembranous sites leads to a dramatic increase in the
stability of calnexin.
Fig 5. Kinetics of calnexin palmitoylation and stability. A: The decay curves were predicted for the different palmitoylation species: fCAL represent folded
calnexin, c1CAL and c2CAL the single palmitoylated species, c12CAL double palmitoylated calnexin. Solid line is the mean of the simulations of 382 models;
shaded area is defined by the first and the third quartile of the simulations of 382 models (details of the in silico labelling experiment can be found in the
Expanded View). B: Decay profiles were determined for WT calnexin either by 35S Cys/Meth labelling (35S calx WT) and by SNAP labeling (Calx WT SNAP).
C: The model was simulated until it reached steady state and the values of the palmitoylation rates under steady state conditions were plotted. Error bars
correspond to first and third quartile of the simulations of 382 models (details of the in silico labelling experiment can be found in the Expanded View). D: The
model was simulated until it reached steady state and the values of the degradation rates under steady state conditions were plotted. Error bars were
determined as in (C).
doi:10.1371/journal.pcbi.1004774.g005
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Cooperativity between the two calnexin palmitoylation sites
The analysis of the steady state distribution of WT and cysteine mutants (Fig 3B) indicates that
two sites are required for stable palmitoylation and suggest that there might be cooperativity
between sites. We therefore estimated the rates of palmitate incorporation at each site, depend-
ing on whether the other site was occupied or not. As shown in Fig 5C, palmitoylation on site 1
is predicted to be drastically more efficient than on site 2. However, if site 1 is already occupied,
site 2 is readily modified. In marked contrast, if site 2 is occupied, site 1 by being positioned
between the transmembrane and the palmitoylated site 2 might be less accessible to the
enzyme. This reaction flux analysis indicates that site 1 is preferentially modified and when this
has occurred, site 2 is rapidly acylated, indicating positive cooperatively between sites 1 and 2.
Efficient degradation of calnexin is predicted to require depalmitoylation
We next simulated the degradation fluxes of the different calnexin species (Fig 5D). Even
though nearly 70% of the protein is dual-palmitoylated at steady state (Fig 3B), the degradation
flux was highest for the non-palmitoylated state. Doubly-palmitoylated calnexin did undergo
degradation, but at a 3 to 4 times slower rate, which is due to the 3 to 4 times lower values of
the degradation rate constants (by parameter estimation using the corresponding experimental
information, S2 Table). Therefore, efficient degradation of calnexin appears to require prior
depalmitoylation by thioesterases.
Estimation of the lag-time separating calnexin synthesis from
palmitoylation
An unexpected and intriguing observation in this study is the slow appearance of the palmitoy-
lated population following synthesis (Fig 3A) and the absence of a plateau in the palmitate
incorporation experiment (Fig 1H). This suggests that there is a lag time between synthesis and
palmitoylation of calnexin. To evaluate this lag time, we derived a stochastic formulation of the
original model of the palmitoylation process, and performed stochastic simulations that
allowed us to track single proteins in the system from synthesis to dual-palmitoylation (Sup-
porting information, S5 Fig). Simulations were performed for 5000 molecules. Of these about
3000 were degraded before any palmitoylation event occurred. For the remaining population,
we determined the frequency distribution of the time required to reach dual-acylation (Fig 6).
Some molecules underwent palmitoylation within a few hours of synthesis (Fig 6). Most how-
ever remained in the non-palmitoylated form for extended periods of time, leading to an aver-
age time of synthesis-to-palmitoylation of 8 hrs (Fig 6).
Phosphorylation is a negative regulator of calnexin palmitoylation
Calnexin and its palmitoylating enzyme DHHC6 are two membrane proteins that reside within
the same two-dimensional space of the ER membrane. The lag time between synthesis and pal-
mitoylation of calnexin could potentially be due to slow diffusion of one of the two molecules.
We therefore determined their mobility using Fluorescence Recovery after Photobleaching
(FRAP) of C-terminally GFP-tagged variants. Both calnexin and DHHC6 showed rapid diffu-
sion with rates of 0.63±0.09 and 0.67±0.13 μm2/s respectively, in close agreement with previ-
ously published rates for calnexin (Fig 7A) [41]. As a control of a slow diffusing membrane
protein [42], we confirmed that Climp63/CKAP4 has a diffusion rate of 0.06±0.01 μm2/s (Fig
7A) [42].
Given the high rates of DHHC6 and calnexin diffusion, slow palmitoylation of calnexin can-
not be explained by a low probability of encounter between the enzyme and the substrate. This
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raised the possibility that calnexin palmitoylation is actively prevented and led us to investigate
the effect of calnexin phosphorylation on its acylation. We generated a triple mutant in which
all three serine phosphorylation sites in the calnexin tail (Ser- 554, 564, 583) were mutated to
alanine (S3A mutant). Remarkably, mutation of the serine phosphorylation sites led to a
~200% increase in palmitoylation during the 2h labelling period (Fig 7B and 7C). Also, kinetics
of 3H-palmitate incorporation, in the absence of protein synthesis, were faster for the S3A
mutant than for WT calnexin (Fig 7D). Consistently, 35S Cys/Meth pulse-chase experiments
revealed that the S3A mutant was far more stable than the WT protein (Fig 7E), in particular
due to the disappearance of the initial rapid decay phase, which in WT is due to degradation of
the non-palmitoylated species. Altogether these observations indicate that palmitoylation of
calnexin is under the negative control of serine phosphorylation.
Discussion
S-palmitoylation is a post-translational modification that is receiving increasing attention as
more and more key cellular events and pathways appear to rely on the reversible acylation of
specific proteins [7, 14]. The dynamics of this modification and the regulatory mechanisms are
however poorly understood. We have here investigated palmitoylation of the key ER chaperone
calnexin [15]. Calnexin shares its ability to promote folding of N-glycosylated proteins with
calreticulin, a soluble ER protein. Calnexin in contrast spans the ER membrane and harbors a
90 residue cytosolic tail. While the transmembrane nature of calnexin was initially thought to
favor the chaperoning of transmembrane proteins, it is increasingly clear that the transmem-
brane domain and cytosolic tail confer additional properties and functions to calnexin which
involve its palmitoylation [17, 20, 28, 43].
Fig 6. Stochastic simulations reveal the average palmitoylation time for calnexin. Single proteins were tracked in 5000 stochastic simulations of the
labelling method described in Expanded View. From the simulations we estimated the average and median time requested for a single molecule of calnexin
to undergo double palmitoylation.
doi:10.1371/journal.pcbi.1004774.g006
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We developed a mathematical model of the palmitoylation cycle that accurately captures
the properties of the system as shown by its predictive power. This combination of modeling
and experimentation led to a variety of interesting, often unexpected, analyses, predictions and
conclusions. First, it highlights the under-appreciated complexity of classical metabolic pulse-
chase experiments. What is referred to as WT–of calnexin or any other protein–is in fact a
complex population of species, the distribution of which evolves with time. In our model, we
have distributed calnexin into 5 species, defined by the folding and palmitoylation status. In
future studies we will increase the complexity of the model, including additional species with
different types of post-translational modifications, such as phosphorylation on three serines of
its cytosolic tail [20], a modification which we find affects its palmitoylation status.
Fig 7. Premature calnexin palmitoylation is prevented by serine phosphorylation. A: Hela cells were transfected 48 hrs with Calnexin-GFP,
GFP-DHHC6 or GFP-Climp63. Cells were submitted to FRAP analysis (see Material and Methods). B-E:HeLa cells were transfected for 24h with calnexin-
WT-HA, calnexin-S3A-HA, calnexin-AA-HA or calnexin-AA-S3A-HA. C: Cells were incubated with 3H-palmitic acid for 2h, washed prior to
immunoprecipitation using anti-HA antibodies. Immunoprecipitates were split into two, run on SDS-PAGE and analyzed either by autoradiography (3H-
palmitate) or Western blotting (anti-HA or anti phospho-calnexin). Autoradiograms were quantified using the Typhoon Imager (Image QuantTool, GE
healthcare). Errors correspond to standard deviations (n = 3). D:Cells were incubated with 3H-palmitic acid for different hours at 37°C, washed prior to
immunoprecipitation using anti-HA antibodies. Immunoprecipitates were split into two, run on SDS-PAGE and analyzed either by autoradiography (3H-
palmitate) or Western blotting and autoradiograms were quantified using the Typhoon Imager (Image QuantTool, GE healthcare). E: Cells were incubated 20
min pulse at 37°C with 35S-methionine/cysteine, washed and further incubated for different times at 37°C. Calnexin were immunoprecipitated and analyzed
by SDS-PAGE. Autoradiography and western blotting were quantified using the Typhoon Imager (Image QuantTool, GE healthcare).
doi:10.1371/journal.pcbi.1004774.g007
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Our analysis also indicates that, while 35S Cys/Met labels a well-defined sub-population–the
one that has been synthesized by the cell during the pulse–, this is by no means the case when
labeling cells with 3H-palmitate. Radiolabeled palmitate can indeed be incorporated into any
molecule that has an unoccupied palmitoylation site but importantly cannot be incorporated
into fully palmitoylated proteins, which in the case of calnexin compose ca. 70% of the total cel-
lular population at steady state. These fully palmitoylated proteins are thus silent in such a 3H-
palmitate pulse-chase analysis.
Most importantly our model provides unprecedented understanding of the palmitoylation
process. In the context of calnexin, we found that the molecule undergoes palmitoylation first
on site 1. Once this has occurred, site 2 can be readily modified. There is thus cooperativity
between site 1 and 2. Depalmitoylation can rapidly occur if a single site is occupied but removal
is drastically slowed down if the two sites are acylated. As a consequence, calnexin is either not
modified or acylated on both sites, the single palmitoylated state being barely populated.
Importantly, the percentage of calnexin that is modified at steady state can be tuned between 0
to 100% by the activity of the DHHC6 palmitoyltransferase. It has recently been shown that
the activity of DHHC6, at least for certain substrates, depends on its association with Seleno-
protein K (selK) [44]. Selk was found to be upregulated by ER stress [45], i.e. when increased
chaperone activity is necessary, which would lead to an increase in DHHC6 activity and
thereby in calnexin protein.
Interestingly, we found that palmitoylation not only affects calnexin function—through
association with the ribosome-translocon complex or ER-mitochondrial interaction sites [17,
19, 20, 28]–but has a drastic effect on its stability, increasing the average half-life of the mole-
cules from 5 to 45hrs. Interestingly however, palmitoylation only occurs, on average, 8 hrs after
the calnexin molecule has been synthesized. This means that, at the population levels, some
80% of the calnexin molecules that a resting cell synthesizes are degraded before they acquire
palmitate and thereby activity. Considering that a resting cell has 500’000 to 1 million copies of
calnexin at steady state [37–39], this implies that 2.5 to 5 million copies were actually synthe-
sized. While 80% of these are degraded in resting cells, they can potentially be mobilized if pal-
mitoylation occurred earlier after synthesis.
This unexpected apparent inefficiency for a protein that has no folding problems (Fig 1C),
combined with the fact that both calnexin–the substrate–and DHHC6 –the enzyme–rapidly
diffuse within the same membrane and thus must have a high probability of encounter, led us
to search for a mechanisms that would actively prevent palmitoylation.
Since calnexin is known to undergo serine phosphorylation, we investigated the potential
impact of this modification on palmitoylation and found that a serine phosphorylation defi-
cient calnexin mutant undergoes greatly accelerated palmitoylation. Our study thus indicates
that cells can post-translationally tune the expression level of calnexin by controlling the kinet-
ics of its palmitoylation via phosphorylation of its cytosolic domain.
In addition to providing important novel insight into the mechanisms by which cells control
the level of chaperone activity in the ER, the mathematical model that we have elaborated pro-
vides a framework to study palmitoylation of other proteins. In particular, a great variety of
type I membrane proteins harbor one or two palmitoylation site in the vicinity of their trans-
membrane domains. It will be of interest to determine whether the rules of cooperativity and 2
site-requirement revealed by calnexin apply to other proteins and how palmitoylation kinetics
of these are controlled. Considering that palmitoylation and depalmitoylation are mediated by
enzymes that maybe themselves undergo cycles of palmitoylation and depalmitoylation [46,
47], this post-translational modification is particularly in need of mathematical modeling to
understand the complexity of its regulation.
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Materials and Methods
Cells, antibodies and reagents
Hela cells were grown in complete MEM (Sigma) supplemented with 10% foetal bovine serum
(FBS), 2 mM L-glutamine, penicillin and streptomycin.
Rabbit antibodies against calnexin were produced in our laboratory against the C-terminal
peptide: CDAEEDGGTVSQEEEDRKPK; anti phospho S583-calnexin were from Abcam
(ab58503), anti-HA and anti-HA-agarose conjugated beads were from Roche (Applied Science,
IN), protein G-agarose conjugated beads from GE Healthcare, HRP secondary antibodies from
Pierce.
Plasmids and transfection
Human calnexin-HA and human calnexin-C501A-C502A-HA, calnexin-C501A-HA (AC), cal-
nexin-C502A-HA (CA), calnexin S554A-S564A-S583A-HA (S3A), calnexin-C501A-C502A--
S554A-S564A-S583A-HA (AAS3A) and human-calnexin-SNAP-HA, dog-HA-calnexin-KDEL
and human DHHC6-myc were cloned in pcDNA3 [19]. For control transfections, we used an
empty pcDNA3 plasmid. Plasmids were transfected into Hela cells for 24 hrs (2 μg cDNA/9.6
cm2 plate) using Fugene (Roche Diagnostics Corporation). To generate GFP fusions, calnexin
and DHHC6 were cloned into the peGFP vector and CKAP4 was cloned into the peCE vector.
RNAi experiments
siRNA against human DHHC6 were purchased from Qiagen (target sequence: gaggtttacga-
tactggttat). As control siRNA we used the following target sequence of the viral glycoprotein
VSV-G: attgaacaaacgaaacaagga. For gene silencing, Hela cells were transfected for 72 h with
100pmol/9.2cm2 dish of siRNA using interferin (Polyplus) transfection reagent.
Radiolabeling experiments
To follow palmitoylation, calnexin expressing cells were incubated 2h or several hours at 37°C
in incubation medium (Glasgow minimal essential medium buffered with 10 mMHepes, pH
7.4) with 200 μCI /ml 3H palmitic acid (American Radiolabeled Chemicals, Inc), washed and
incubated different times at 37°C with complete medium prior to immunoprecipitation using
anti-calnexin or anti-HA antibodies. Beads were incubated 5 min at 90°C in reducing sample
buffer prior to SDS-PAGE. Immunoprecipitates were split into two, run on 4–20% gels and
analyzed either by autoradiography (3H-palmitate) after fixation (25% isopropanol, 65% H2O,
10% acetic acid), gels were incubated 30 min in enhancer Amplify NAMP100 (Amersham) and
dried or submitted to Western blotting (anti-calnexin). Autoradiograms and western blotting
were quantified using the Typhoon Imager (Image QuantTool, GE healthcare).
For metabolic labeling, Hela cells were transiently transfected (24h) or not with calnexin-
HA cDNAs, washed with methionine /cysteine free medium, incubated 20 min pulse at 37°C
with 50 μCi/ml 35S-methionine/cysteine (Hartman Analytics), washed and further incubated
for different times at 37°C in complete medium with a 10-fold excess of non-radioactive methi-
onine and cysteine. Calnexin were immunoprecipitated and analyzed by SDS-PAGE.
Protein synthesis was blocked by 30 min treatment with 10 μg/ml cycloheximide (Sigma) at
37°C.
Immunoprecipitation
For immunoprecipitations, cells were lysed 30 min at 4°C in IP buffer (0.5%NP40, 500 mM
Tris-HCl pH 7.4, 20 mM EDTA, 10 mMNaF, 2 mM benzamidine, and a cocktail of protease
Palmitoylation Dynamics of the Chaperone Calnexin
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004774 February 22, 2016 16 / 23
inhibitors, Roche), centrifuged 3 min at 2000 g and supernatants were pre-cleared with protein
G-agarose conjugated beads and supernatants were incubated 16 h at 4°C with antibodies and
beads.
SNAP labeling
To follow SNAP labeling, calnexin-SNAP expressing cells were incubated 6 hours with 10 μg/
ml cycloheximide at 37°C in complete medium, then 30min at 37°C in complete medium with
1 μM SNAP-cell-TMR-star (Biolabs) and cycloheximide, then washed three times and incu-
bated different times at 37°C with complete medium prior lysis of the cells. Total cell lysates
were analyzed by SDS-PAGE and the fluorescence was measured using the Typhoon Imager
(Image QuantTool, GE healthcare).
Fluorescence recovery after photobleaching
HeLa cells were seeded on FluoroDish (glass bottom: 0.17mm thickness, fromWorld Precision
Instrument Inc. USA) and GFP-tagged proteins (calnexin, DHHC6 and Climp63) were tran-
siently expressed for 24 hours. Fluorescence recovery after photobleaching (FRAP) experi-
ments were performed on a Leica SP5 microscope using a 63x oil-immersion objective (1.4
NA). The microscope was operated using the software supplied with the instrument (LAS AF
2009). The 488nm line of the argon laser was set at 60% output and 100% transmission. During
the experiment, the cells were kept in a chamber at 37°C and 5% CO2. The pinhole was wide-
open. The scanner speed was set at 1400Hz. The digital zoom was set at 6. The detector gain
was set at 740V. The frame size was set at 512x32. The resulting scanning time was 32ms per
frame. Point bleach measurements were performed and the effective radius of the bleached
area was calculated as 0.9μm according to [48]. 50 iterations using 4% transmission of the laser
were acquired as pre-bleach reference scans. Then the GFP-tagged proteins localized in the ER
were bleached a single iteration for 5ms. Afterwards 500 post-bleach iterations were acquired
with same settings as for the pre-bleach acquisitions. FRAP experiments were conducted for
each condition on 12 different cells expressing the same level of GFP-tagged proteins. Longer
post-bleach acquisitions were conducted for Climp63 to enable a better exponential fitting of
the post-bleach curves. Diffusion coefficients were extracted (according to [49]) from the fit-
ting of an exponential equation to the post-bleach recovery curves using a hand-made code in
matlab (MATLAB 8.0 and Statistics Toolbox 8.1, The MathWorks, Inc. USA).
Supporting Information
S1 Fig. Results of the GA optimization are plotted on top of the experimental data used as
objectives. (G-L): Results of the GA optimization are plotted on top of the experimental data
used as validation. A-F: In order to estimate the parameters of the model the following set of
experiments were used. The algorithm used for estimation is gamultiobj from MATLAB’s
global optimization toolbox. This algorithm finds the overall minimum of multiple objective
functions by minimizing the difference between the output of the model and the experimental
data of the calibration set. The goodness of the fitting is visualized plotting the output of the in
silico experiment obtained with the model on top of the corresponding experimental data: A:
ACmutant 35S decay; B:WT 35S decay; C:WT 3H incorporation (data are relative to the t = 1h
point);D: ACmutant 3H decay; E: AAmutant 35S decay; F:WT 3H decay. G-L: In order to
ensure that the model was able to capture behaviors of experiments for which it wasn’t trained
we used the following set of experiments to validate the output of the model. These experi-
ments were not used to estimate the parameters of the model, therefore its output is a predic-
tion of the result of the different experiments. This analysis ensures that the model is able to
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make reliable predictions for different experiments and not only for the ones that were used to
estimate the parameters. The goodness of the predictions is visualized plotting the output of
the in silico experiment obtained with the model on top of the corresponding experimental
data: G: Calnexin WT PAT6 Overepression 35S decay;H: Calnexin CA mutant 35S decay; I:
Calnexin CA mutant 3H decay; L: Calnexin WT PAT6 Silencing 35S decay.
(EPS)
S2 Fig. Schematic representation of the model and the procedure used for 35S pulse-chase
experiments simulation. A:Model scheme used for 35S labelling simulations. The labeled spe-
cies are marked with . B:Qualitative representation of the method used to perform 35S in silico
labeling experiments. Each simulation is performed in 3 phases. 1) Steady state: the model of
the endogenous calnexin is simulated until it reaches steady state. 2) Labeling: the synthesis
term is switched towards the labeled protein (marked with ) to simulate the addition of the
label for a time that matches the experiments. 3) Analysis: the synthesis term is switched again
towards endogenous calnexin to simulate the removal of the labeling. The decay of the labeled
species is observed at the same time point of the experiments.
(EPS)
S3 Fig. Schematic representation of the model and the procedure used for 3H pulse-chase
experiments simulation. A:Model scheme used for 3H labelling simulations. The labeled spe-
cies are marked with . B:Qualitative representation of the steps used to perform 3H in silico
labelling experiments. Each simulation is performed in 3 phases. 1) Steady state: the model of
the endogenous calnexin is simulated until it reaches steady state. 2) Labeling: the reactions of
palmitate attachment are switched towards the labeled protein (marked with ) to simulate the
addition of the 3H palmitate for a time that matches the experiments. 3) Analysis: the reactions
of palmitate attachment switched again towards endogenous calnexin to simulate the removal
of the radiolabelled palmitate. The decay of the labeled species is observed at the same time
point of the experiments.
(EPS)
S4 Fig. Distribution of the labeled species in the different palmitoylation states after 2
hours labeling with 3H palmitate. The relative amount of labelled protein with respect to the
total pool of calnexin inside the cell (2 hours palmitate labelling) is also shown.
(EPS)
S5 Fig. Qualitative representation of the procedure used for protein tracking with stochas-
tic simulations, along with proof of convergence. A: Each simulation is performed in 2
phases. 1) Steady state: the model is simulated until the pool of endogenous calnexin is in steady
state. 2) Analysis: a single calnexin molecule is added to the pool of labeled protein (marked
with ), and its route is recorded at each time step. Analysis of the route allows to calculate the
time for going from synthesis to the double palmitoylation state. B: The average palmitoylation
time measured have converged to 8h after 1100 event of double palmitoylation tracked. We per-
formed 5000 single molecule tracking simulations. During these simulations only 1100 molecule
were able to get double palmitoylated before getting degraded. Here we reported the cumulative
average palmitoylation time to show that the measured value converged to 8h.
(EPS)
S6 Fig. Steady state sensitivity analysis of calnexin WT and mutants. In order to determine
to which parameters the steady state of calnexin is most sensitive we performed sensitivity
analysis on WT and mutants.
(EPS)
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S7 Fig. Half life sensitivity analysis of calnexin WT. Experimental data and the analysis of
the model parameters have shown how palmitoylation affects stability of calnexin. Sensitivity
analysis on in-silico 35S experiments confirm that the protein half life is strongly influenced by
the ability of calnexin of being palmitoylated.
(EPS)
S8 Fig. Half life sensitivity analysis of calnexin AA mutant. Sensitivity analysis on in-silico
35S experiments on the AA calnexin mutant shows that if the protein can’t be palmitoylated, it
loses the capabilities to regulate its half-life. The stability of the protein become dependent
from the degradation rate of the non palmitoylated state only.
(EPS)
S9 Fig. Half life sensitivity analysis of calnexin AC mutant. Sensitivity analysis on in-silico
35S experiments on the AC calnexin mutant. Results show that a single palmitoylation site is
not enough to increase the stability of the protein which remain dependent only from the deg-
radation rate of the non palmitoylated state only.
(EPS)
S10 Fig. Half life sensitivity analysis of calnexin CA mutant. Sensitivity analysis on in-silico
35S experiments on the CA calnexin mutant confirm that the presence of only 1 site isn’t
enough to be able to regulate the stability of the protein. If compared with S9 Fig it is possible
to see how the two sites are not equivalent, palmitoylation of the first site influence more the
stability of calnexin.
(EPS)
S11 Fig. Fitting of the data used for calibration and validation after averaging the 383 sets
of parameters estimated by the GA. In order to estimate a unique set of parameters for the
stochastic simulations the 383 sets of parameter where averaged to obtain a single parameter
set that was then converted to stochastic. The figure shows that the averaged set of parameters
is still able to reproduce both the calibration and validation data.
(EPS)
S1 Text. S1 Text contains detailed information about the model formulation, tQSSA appli-
cation, parametrization, description of in-silico experiments, stochastic model formulation
and explanations of the analysis performed on stochastic data.
(DOCX)
S1 Table. Model reactions. The model of calnexin palmitoylation contains 14 different reac-
tions, describing synthesis, folding, degradation, and the enzymatic reactions of calnexin pal-
mitoylation/depalmitoylation. In the following table we describe in detail how the rates for
those reactions are calculated.
(DOCX)
S2 Table. Model parameters. The output of GA is a set of optimal solutions, where a solution
is a complete set of parameter needed to perform model simulations. From this set we extracted
a sub-set of 382 solutions which obtained a GA score better than a set threshold for each objec-
tive. During the analysis the model was simulated for each set of parameters of the sub-set. We
then reported in this paper the mean of the outputs along with the 1st and 3rd quartile of their
distribution.
(DOCX)
S3 Table. Mass balance equations. In this model calnexin can exist in 5 different states:
unfolded (rCAL), folded (fCAL), palmitoylated only on the first site (c1CAL) or the second
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(c2CAL), or dually palmitoylated (c12CAL). The following table describes the mass balance for
each of these species. The rates of the mass balance of each state are described in detail in S1
Table.
(DOCX)
S4 Table. Stoichiometric matrix used for stochastic simulations. In the following table we
define the stoichiometry and the directionality of the reactions of the model. Each reaction has
a directionality that define which are the reagents and which are the products. In this table
each line represents a model reaction, while in the columns we find all the states of the model.
For each reaction the states of the model that take part to the reaction as reagents are marked
with -1, while the states that participate as products are marked with 1. The matrix that is
formed in this way allow to attribute the correct directionality to model reactions during the
calculation of the mass balance for each state of the model.
(DOCX)
S5 Table. Propensity function used for stochastic simulations. In the first column of the
table, each line describes a reaction of the model. To each reaction is associated a rate, in the
second column, that describes the probability of that reaction to happen at each time step of
the stochastic simulation.
(DOCX)
S6 Table. Parameters used for stochastic simulations. The following parameters were
obtained through the conversion of the deterministic parameters estimated by the GA (see
“Conversion of deterministic parameters to stochastic”).
(DOCX)
S7 Table. Experimental data for Figs 1 and 2. Due to the small deviation that characterize the
set of experimental data used for generating Figs 1 and 2, the error bars in those figures are not
clearly visible. Therefore we report here the numeric data for those experiments.
(DOCX)
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